Inovio Pharmaceuticals Inc (INO) earnings · rev $65.3K
These earnings events as JSON? API free 100/dayInovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
This INO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.
When the next INO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 70.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full INO research stays on the stock page; the tape stays on the quote page.
INO earnings FAQ
What are INO's latest revenue and net income?
Latest cached Inovio Pharmaceuticals Inc (INO) revenue for Dec 31, 2025 was $65.3K. Net income was -$84.9M. Statements: https://lician.com/financials/ino
What is INO's latest diluted EPS?
Latest cached Inovio Pharmaceuticals Inc (INO) diluted EPS for Dec 31, 2025 was -$1.81.
What period does the latest INO earnings print cover?
The latest cached Inovio Pharmaceuticals Inc (INO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did INO revenue change from the prior cached period?
Cached Inovio Pharmaceuticals Inc (INO) revenue was down 70.0% from $217.8K (Dec 31, 2024) to $65.3K (Dec 31, 2025). Statements: https://lician.com/financials/ino
Where are INO earnings listed?
Cached earnings facts for Inovio Pharmaceuticals Inc (INO) are listed at https://lician.com/earnings/ino. Statements: https://lician.com/financials/ino
Not investment advice.